EMTRICITABINE/TENOFOVIR DISOPROXIL (Ictastan®)

Clinical Indication

HIV

Date of classification

April 2019

Review date

April 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).